Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia

Schizophr Res. 2007 Jan;89(1-3):350-2. doi: 10.1016/j.schres.2006.08.020. Epub 2006 Oct 6.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Appetite / drug effects
  • Benzodiazepines / adverse effects
  • Benzodiazepines / therapeutic use
  • Blood Glucose / metabolism
  • Chronic Disease
  • Delayed-Action Preparations
  • Female
  • Fluphenazine / analogs & derivatives
  • Fluphenazine / therapeutic use
  • Humans
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Male
  • Olanzapine
  • Reference Values
  • Risperidone / adverse effects*
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology
  • Weight Gain / drug effects

Substances

  • Antipsychotic Agents
  • Blood Glucose
  • Delayed-Action Preparations
  • Insulin
  • Benzodiazepines
  • fluphenazine depot
  • Risperidone
  • Olanzapine
  • Fluphenazine